查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1629186

白喉、百日咳和破傷風 (DPT) 疫苗市場，按類型、年齡層、最終用戶、國家和地區 - 2024-2032 年行業分析、市場最終用戶、市場佔有率和預測

Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market, By Type, By Age Group, By End User, By Country, and By Region - Industry Analysis, Market End User, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年白喉、百日咳和破傷風(DPT)疫苗市場最終用戶價值為56.2032億美元，2024年至2032年複合年成長率為8.30%。

白喉、百日咳和破傷風 (DPT) 疫苗市場-市場動態

嬰兒和兒童中百白破相關疾病的盛行率不斷上升，以及政府計劃提高意識，預計將推動市場需求

政府和組織加強教育人們疫苗接種的重要性，這正在促進市場成長。世衛組織的擴大免疫規劃 (EPI) 和全球疫苗免疫聯盟 (疫苗聯盟) 等計畫強調需要針對與百白破 (DPT) 相關的疾病進行廣泛的免疫接種。對白喉、百日咳和破傷風風險（尤其是兒童）風險的進一步了解推動了需求。此外，百白破疫苗納入國家免疫規劃也刺激了市場需求。許多政府以很少的成本或免費提供疫苗，使服務不足的人能夠獲得疫苗。

嬰兒和幼兒特別容易感染百白破相關疾病。在非洲和亞洲部分地區等出生率較高的國家或地區，五歲以下兒童數量的不斷增加推動了對百白破疫苗的需求。 DPT 通常與其他疫苗如B型肝炎、小兒麻痺症結合使用，以便於管理，提高市場滲透率。此外，疫苗儲存和分發方面的進步增強了偏遠地區的可及性。由於免疫力下降而導致百日咳定期爆發，凸顯了加強劑量和高疫苗接種率的必要性。白喉和百日咳等疾病的根除和控制工作優先考慮百白破疫苗。消除孕產婦和新生兒破傷風 (MNT) 計畫等措施支持持續接種疫苗。

白喉、百日咳和破傷風 (DPT) 疫苗市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 8.30% 左右的複合年成長率成長

根據類型細分，預計 DTaP 疫苗細分市場將在 2023 年顯示最大市場佔有率，這主要歸功於世衛組織的建議。

根據年齡層細分，由於世界衛生組織規範制定了強制性百白破疫苗，兒科細分市場在 2023 年成為領先的年齡層細分市場。

根據最終用戶細分，醫院細分市場是 2023 年領先的最終用戶細分市場，這主要是由於人們對醫院疫苗接種和專案的認知不斷提高。

從地區來看，由於亞洲國家人口的成長，亞太地區是 2023 年的主要收入來源。

白喉、百日咳和破傷風 (DPT) 疫苗市場-細分分析：

全球白喉、百日咳和破傷風 (DPT) 疫苗市場根據類型、年齡層、最終用戶和地區進行細分。

市場依類型分為三類：DTaP疫苗、TD疫苗和TDaP疫苗。 DTaP 疫苗領域在市場上佔據主導地位。預防傳染病流行的日益成長的需求正在推動該細分市場的成長。

市場依年齡層分為兩類：成人和兒童。兒科領域在市場上佔據主導地位。兒科團體對疫苗接種前計劃的認知不斷提高，主要補充了細分市場的成長。

根據最終用戶，市場分為三類：醫院、診所和其他。預計醫院部門在預測期內將以最快的速度成長。世界衛生組織和聯合國兒童基金會以消除孕產婦破傷風、小兒麻痺為目標的疫苗接種計畫數量不斷增加，預計將促進市場需求。

白喉、百日咳和破傷風 (DPT) 疫苗市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。在北美，由於嚴格的公共衛生規定，疫苗接種覆蓋率很高。完善的醫療基礎設施確保了疫苗的廣泛普及。在亞太地區，由於印度、中國和東南亞等國家的高出生率和大量嬰兒人口而迅速成長。全球疫苗和免疫聯盟、世界衛生組織等全球組織對低收入地區免疫規劃的支持。印度和中國都是主要市場，既是疫苗消費國，也是疫苗生產國。

白喉、百日咳和破傷風 (DPT) 疫苗市場-競爭格局：

白喉、百日咳和破傷風（DPT）疫苗市場的特點是各大製藥公司之間競爭激烈、不斷創新和策略合作夥伴關係。市場正在轉向先進的組合疫苗，如五價和六價製劑，其中包括針對B型肝炎和 Hib 等疾病的額外抗原。這些創新減少了綜合免疫計畫所需的注射次數。強生公司、葛蘭素史克、血清研究所、Bionet-Asia 和明治控股是百白破疫苗領域的一些知名參與者。

2023年，賽諾菲巴斯德在美國市場推出六合一免疫疫苗Hexacima。

2022 年，默克公司與 Thermos 合作增強疫苗儲存和分配技術。

目錄

第 1 章：白喉、百日咳和破傷風 (DPT) 疫苗市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 白喉、百日咳和破傷風 (DPT) 疫苗市場摘要（按類型）
    • 白喉、百日咳和破傷風 (DPT) 疫苗市場片段（按年齡層）
    • 白喉、百日咳和破傷風 (DPT) 疫苗市場片段（按最終用戶）
    • 白喉、百日咳和破傷風 (DPT) 疫苗市場片段（按國家/地區）
    • 白喉、百日咳和破傷風 (DPT) 疫苗市場片段（按地區）
  • 競爭洞察

第 3 章：白喉、百日咳和破傷風 (DPT) 疫苗主要市場趨勢

  • 白喉、百日咳和破傷風 (DPT) 疫苗市場促進因素
    • 市場促進因素的影響分析
  • 白喉、百日咳和破傷風 (DPT) 疫苗市場限制
    • 市場限制影響分析
  • 白喉、百日咳和破傷風 (DPT) 疫苗市場機會
  • 白喉、百日咳和破傷風 (DPT) 疫苗市場未來趨勢

第 4 章：白喉、百日咳和破傷風 (DPT) 疫苗產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：白喉、百日咳和破傷風 (DPT) 疫苗市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：白喉、百日咳和破傷風 (DPT) 疫苗市場格局

  • 2023 年白喉、百日咳和破傷風 (DPT) 疫苗市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：白喉、百日咳和破傷風 (DPT) 疫苗市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 百白破疫苗
    • TD 疫苗
    • TDaP 疫苗

第 8 章：白喉、百日咳和破傷風 (DPT) 疫苗市場 - 按年齡層

  • 概述
    • 按年齡層別分類的細分市場佔有率分析
    • 成年人
    • 兒科

第 9 章：白喉、百日咳和破傷風 (DPT) 疫苗市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院
    • 診所
    • 其他

第 10 章：白喉、百日咳和破傷風 (DPT) 疫苗市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美白喉、百日咳和破傷風 (DPT) 疫苗主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按類型）
    • 北美市場規模和預測（按年齡層）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲白喉、百日咳和破傷風 (DPT) 疫苗主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模和預測（按年齡層）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區白喉、百日咳和破傷風 (DPT) 疫苗主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按類型）
    • 亞太地區市場規模與預測（依年齡層）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲白喉、百日咳和破傷風 (DPT) 疫苗主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按類型）
    • 拉丁美洲市場規模與預測（按年齡層）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲白喉、百日咳和破傷風 (DPT) 疫苗主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按類型）
    • 中東和非洲市場規模及預測（按年齡層）
    • 中東和非洲市場規模及預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 白喉、百日咳和破傷風 (DPT) 疫苗產業

  • 競爭儀表板
  • 公司簡介
    • GlaxoSmithKline (GSK)
    • Sanofi Pasteur
    • Merck & Co.
    • Serum Institute of India
    • Biological E Limited
    • Pfizer Inc.
    • Johnson & Johnson
    • CSL Limited
    • China National Pharmaceutical Group Corporation
    • Bharat Biotech
    • Novartis AG
    • Panacea Biotec
    • Valneva SE
    • Bionet-Asia
    • Meiji Holdings Co., Ltd.
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4492

REPORT HIGHLIGHT

Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market End User was valued at USD 5,620.32 Million in 2023, expanding at a CAGR of 8.30% from 2024 to 2032.

The Diphtheria, Pertussis, and Tetanus (DPT) vaccine is a combination vaccine that provides protection against serious bacterial infections. These vaccines reduce the risk of infection and serious complications, especially in young children.

Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market- Market Dynamics

Increasing prevalence of DPT-related diseases among infant & children and rising awareness spread by government programs is expected to propel market demand

Increased efforts by governments and organizations to educate populations about the importance of vaccination is promoting market growth. Programs like WHO's Expanded Program on Immunization (EPI) and GAVI, the Vaccine Alliance, emphasize the need for widespread immunization against DPT-related diseases. Improved understanding of the risks of diphtheria, pertussis, and tetanus, particularly in children, drives demand. Also, the inclusion of the DPT vaccine in national immunization schedules boosts market demand. Many governments provide vaccines at little or no cost, making them accessible to underserved populations.

Infants and young children are particularly susceptible to DPT-related diseases. In the countries or regions with high birth rates, such as Africa and parts of Asia, the growing number of children under five drives the need for DPT vaccines. DPT is often combined with other vaccines like hepatitis B, polio for ease of administration, improving market penetration. Additionally, advancements in vaccine storage and distribution enhance accessibility in remote areas. Periodic pertussis outbreaks due to waning immunity have underscored the need for booster doses and high vaccination rates. Eradication and control efforts for diseases like diphtheria and pertussis prioritize DPT vaccines. Initiatives like maternal and neonatal tetanus (MNT) elimination programs support consistent vaccine uptake.

Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.30% over the forecast period (2024-2032)

Based on Type segmentation, the DTaP vaccines segment was predicted to show maximum market share in the year 2023, mainly owing to WHO's recommendation.

Based on Age Group segmentation, the pediatrics segment was the leading Age Group segment in 2023, due to mandatory DTP vaccines made by WHO norms.

Based on End User segmentation, the hospitals segment was the leading End User segment in 2023, mainly due to rising awareness among people about vaccination & programs by hospitals.

On the basis of region, Asia Pacific was the leading revenue generator in 2023, due to the rise in the population across Asian countries.

Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market- Segmentation Analysis:

Global Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market is segmented on the basis of Type, Age Group, End User, and Region.

The market is divided into three categories based on the Type: DTaP vaccines, TD vaccines, and TDaP vaccines. The DTaP vaccines segment dominates the market. The growing need to prevent infectious disease prevalence is boosting segment growth.

The market is divided into two categories based on Age Group: adults and pediatrics. The pediatrics segment dominates the market. The increasing awareness among pediatrics groups about pre-vaccination programs is primarily supplementing segment growth.

The market is divided into three categories based on End User: hospitals, clinics, and others. The hospital segment is anticipated to grow at the fastest rate over the forecast period. The growing number of vaccination programs with WHO & UNICEF goals with maternal tetanus elimination, polios are expected to foster market demand.

Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. In North America, there is high vaccination coverage due to stringent public health mandates. Established healthcare infrastructure ensures widespread vaccine access. In Asia Pacific, rapidly growing due to high birth rates and large infant populations in countries like India, China, and Southeast Asia. Support from global organizations such as GAVI, WHO for immunization programs in low-income areas. India and China are major markets, both as vaccine consumers and producers.

Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market- Competitive Landscape:

The Diphtheria, Pertussis, and Tetanus (DPT) vaccine market is characterized by intense competition among major pharmaceutical companies, continuous innovations, and strategic partnerships. The market is moving towards advanced combination vaccines like pentavalent and hexavalent formulations, which include additional antigens for diseases like hepatitis B and Hib. These innovations reduce the number of injections required for comprehensive immunization programs. Johnson & Johnson, GSK, Serum Institute, Bionet-Asia, and Meiji Holdings are some of the prominent players in the DPT vaccine space.

In 2023, Sanofi Pasteur launched Hexacima a six in a one immunization Vaccine in the U.S. market.

In 2022, Merck & Co. collaborated with Thermos to enhance vaccine storage and distribution technologies.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DIPHTHERIA, PERTUSSIS, AND TETANUS (DPT) VACCINE MARKET KEY PLAYERS

  • GlaxoSmithKline (GSK)
  • Sanofi Pasteur
  • Merck & Co.
  • Serum Institute of India
  • Biological E Limited
  • Pfizer Inc.
  • Johnson & Johnson
  • CSL Limited
  • China National Pharmaceutical Group Corporation
  • Bharat Biotech
  • Novartis AG
  • Panacea Biotec
  • Valneva SE
  • Bionet-Asia
  • Meiji Holdings Co., Ltd.
  • Others

GLOBAL DIPHTHERIA, PERTUSSIS, AND TETANUS (DPT) VACCINE MARKET, BY TYPE- MARKET ANALYSIS, 2019-2032

  • DTaP vaccines
  • TD vaccines
  • TDaP vaccines

GLOBAL DIPHTHERIA, PERTUSSIS, AND TETANUS (DPT) VACCINE MARKET, BY AGE GROUP- MARKET ANALYSIS, 2019-2032

  • Adults
  • Pediatrics

GLOBAL DIPHTHERIA, PERTUSSIS, AND TETANUS (DPT) VACCINE MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospitals
  • Clinics
  • Others

GLOBAL DIPHTHERIA, PERTUSSIS, AND TETANUS (DPT) VACCINE MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Snippet by Type
    • 2.1.2. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Snippet by Age Group
    • 2.1.3. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Snippet by End User
    • 2.1.4. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Snippet by Country
    • 2.1.5. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Snippet by Region
  • 2.2. Competitive Insights

3. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Key Market Trends

  • 3.1. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Opportunities
  • 3.4. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Future Trends

4. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Landscape

  • 6.1. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. DTaP vaccines
    • 7.1.3. TD vaccines
    • 7.1.4. TDaP vaccines

8. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market - By Age Group

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Age Group, 2024 & 2032 (%)
    • 8.1.2. Adults
    • 8.1.3. Paediatrics

9. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Others

10. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Diphtheria, Pertussis, and Tetanus (DPT) Vaccine Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. GlaxoSmithKline (GSK)
    • 11.2.2. Sanofi Pasteur
    • 11.2.3. Merck & Co.
    • 11.2.4. Serum Institute of India
    • 11.2.5. Biological E Limited
    • 11.2.6. Pfizer Inc.
    • 11.2.7. Johnson & Johnson
    • 11.2.8. CSL Limited
    • 11.2.9. China National Pharmaceutical Group Corporation
    • 11.2.10. Bharat Biotech
    • 11.2.11. Novartis AG
    • 11.2.12. Panacea Biotec
    • 11.2.13. Valneva SE
    • 11.2.14. Bionet-Asia
    • 11.2.15. Meiji Holdings Co., Ltd.
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us